HYTHIAM (NASDAQ:HYTM)
0.36
-0 (-0%)
| HYTHIAM (NASDAQ:HYTM) Delayed : |
| Previous Close |
$0.36 |
|
52 Week High |
$1.09 |
|
| Open |
$0.35 |
|
52 Week Low |
$0.17 |
| Day High |
$0.39 |
|
P/E |
N/A |
| Day Low |
$0.33 |
|
EPS |
$-0.73 |
| Volume |
975,165 |
|
|
|
| More HYTM Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on HYTM
-
Nov 9, 2009 04:22 PM
Hythiam (HYTM) Posts Q3 Loss of $0.16, Down from Q308
-
Sep 28, 2009 08:20 AM
Hythiam (HYTM) Says Published Study Shows Statistically Significant Results
-
Sep 17, 2009 02:32 PM
Hythiam (HYTM) Uses Strength From News to Sell Stock
-
Sep 17, 2009 09:43 AM
Hythiam (HYTM) Rockets Higher On Substance Abuse Deal With Ford
-
Sep 17, 2009 09:37 AM
Morning Movers 9/17: HYTM, IVAN, XNPT, RNN, BSTC, AMR, SOLF Higher; DARA, SNV, HW Lower
View All Reports
StreetInsider Reports on HYTM by Category
Comments on recent HYTM articles
Comments on HYTM
No comments are currently available.
on Jun 3, 2008
at 06:38 PM Reimbursement deals = success As 30 year addictions treatment veteran, I watched the "for profit" addictions treatment industry implode as insurer reimbursements dwindled to nearly nothing. There is very little treatment out there that actually works. If clinical trials prove the treatment is effective, and if an increasing number of insurers agree to reimburse for treatment, then HYTM will be a great success...and a profitable one for investors.
Article: Hythiam (HYTM) Higher Following Upbeat Analyst Comments